An approved medicine that acts on brain signals tied to sexual desire.

What does the research on PT-141 show?

In studies in women with low sexual desire, some reported improvement. It is approved for that use.

What is still unknown about PT-141?

How large the benefit really is day to day, and how well it works for anyone else.

Approved medicine

The FDA has approved a version of this as a medicine, so it has been through large studies in people.

Also called Bremelanotide / Vyleesi / Melanocortin agonist

A medicine acting on brain signals linked to sexual desire, approved for low desire in premenopausal women.

What is it?: An approved medicine that acts on brain signals tied to sexual desire.
What do we know?: In studies in women with low sexual desire, some reported improvement. It is approved for that use.
What do we still not know?: How large the benefit really is day to day, and how well it works for anyone else.

Yes. Pharmacies are allowed to make it, so a doctor can write a prescription for it.

The FDA has approved a version of this as a medicine.

FDA approved as bremelanotide for hypoactive sexual desire disorder in premenopausal women.

Official status: On the 503A bulks list. Checked 2026-06-05.

Lab suppliers we list: 14

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

No dosing information has been published in the research indexed here.